Palynziq provides a significant new genotype-independent therapy for patients 12 years and older to help manage and reduce blood phenylalanine levels.
Stephanie Sacharow, MD
Advertisement
Stephanie Sacharow, MD, is a director at Boston Children’s Hospital.
Articles by Stephanie Sacharow, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Jamie Wood, MD, on the significance of the Afrezza approval for pediatric diabetes
2
How to recognize and when to refer for children with hidradenitis suppurativa
3
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
4
Simple screening questions may help pediatricians identify hidradenitis suppurativa earlier
5